Recombinant modified vaccinia Ankara (MVA) vaccinia virus containing restructured insertion sites

Details for Australian Patent Application No. 2010306559 (hide)

Owner The U.S.A. as represented by the Secretary, Department of Health and Human Services .

Inventors Moss, Bernard; Wyatt, Linda S.; Earl, Patricia L.

Agent FB Rice

Pub. Number AU-A-2010306559

PCT Pub. Number WO2011/047324

Priority 61/252,326 16.10.09 US

Filing date 15 October 2010

Wipo publication date 21 April 2011

International Classifications

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/047324 Priority application(s): WO2011/047324

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010306563-Antibody therapeutics with local activity in the digestive tract

2010306542-Electromagnetic field detection systems